FoxD2-AS1 is a prognostic factor in glioma and promotes temozolomide resistance in a O(6)-methylguanine-DNA methyltransferase-dependent manner

Glioma is the most common brain tumor with a dismal prognosis. While temozolomide (TMZ) based chemotherapy significantly improves survival in glioma patients, resistance against this compound commonly leads to glioma treatment failure. Overexpression of long-noncoding RNA (LncRNA) FoxD2 adjacent opp...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Korean J Physiol Pharmacol
Главные авторы: Shangguan, Wenbing, Lv, Xuyang, Tian, Nan
Формат: Artigo
Язык:Inglês
Опубликовано: The Korean Physiological Society and The Korean Society of Pharmacology 2019
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6819902/
https://ncbi.nlm.nih.gov/pubmed/31680769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4196/kjpp.2019.23.6.475
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы